Advances in Treatment of Recurrent/Metastatic Head and Neck Cancers

Emrullah Yilmaz, MD, PhD.
Clevland Clinic
Hematology and Medical Oncology

JOIN HERE!

Objectives

At the end of the presentation, participants will be able to:

• Analyze current treatment options for recurrent/metastatic head and neck cancers
• Revise novel immunotherapy and combination strategies for recurrent/metastatic head and neck cancers
• Explain identification of high-risk patients for recurrence/metastasis

Faculty Disclosure

Dr. Yilmaz has indicated the following relevant financial relationships with commercial interests:

Financial Relationship                                          Commercial Interest/Organization
Advisor                                                                   Astellas Pharma
Researcher                                                              Bicara Theraputics, Hookipa Pharma, Merus

Planning Committee Disclosure

Dr. Lekakis, has indicated that he has no relevant financial relationships with commercial interests.

Target Audience

Faculty, Primary Care Physicians, APRNs, PharmD

Accreditation

The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.